Wistar researchers have demonstrated roles for that gene in both cancer and stem cell biology

Funds from Walloon are in the form of recoverable cash advances, and will be used to industrialize some projects, including production of lead product C3BS-CQR-1 (C-Cure), a stem cell therapy for heart failure

Amarin plans to use proceeds to fund the commercial launch of triglyceride-lowering compound AMR101 (ethyl icosapentate) and the patient enrollment in a cardiovascular outcomes study of the compound...Vibativ was approved in Europe last year for the treatment of adults with nosocomial pneumonia, including ventilator-associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus (MRSA) when other alternatives aren't suitable

A therapy comprising allogeneic bone marrow-derived mesenchymal stem cells harvested from healthy adult donors, AC607 recently completed a Phase I trial, in which it demonstrated a good safety profile and suggested an ability to reduce both the incidence of AKI and length of hospital stay in cardiac surgery patients

BioTime Inc., of Alameda, Calif., said it elected to market progenitors of muscle stem cells bearing hereditary diseases and will produce products from five human embryonic stem cells lines from the Reproductive Genetics Institute of Chicago

Gentium SpA, of Villa Guardia, Italy, said it received the list of questions from the European Committee for Medicinal Products for Human Use in response to its marketing application for defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation therapy...TiGenix NV, of Leuven, Belgium, and its subsidiary Cellerix SA, of Tres Cantos, Spain, will receive about $3.8 million from the European Seventh Framework Programme to

Gentium SpA, of Villa Guardia, Italy, said it received the list of questions from the European Committee for Medicinal Products for Human Use in response to its marketing application for defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation therapy

TiGenix NV, of Leuven, Belgium, and its subsidiary Cellerix SA, of Tres Cantos, Spain, will receive about $3.8 million from the European Seventh Framework Programme to support the development of their Cx611 program of allogeneic expanded adipose-derived stem cells to treat rheumatoid arthritis

Cellzome AG, of Heidelberg, Germany, received a grant for €1.1M (US$1.5 million) over two years from the UK's Technology Strategy Board under its regenerative medicine program for a project to improve the characterization of human stem cells...Cellzome will use its Episphere technology in collaboration with Neusentis, a Cambridge, UK, subsidiary of New York-based Pfizer Inc., the University of Sheffield and Plasticell Ltd., of London, to identify protein fingerprints that predict potentially

VistaGen Therapeutics Inc., of South San Francisco, is collaborating with Synterys Inc., of Union City, Calif., to further VistaGen's stem cell technology-based drug rescue initiatives...The collaboration will combine VistaGen's human pluripotent stem cell technology platform with modern medicinal chemistry to generate new chemical variants of once-promising small-molecule drug candidates that industry and other researchers discontinued during preclinical development due to toxicity issues

Cellzome AG, of Heidelberg, Germany, received a grant for €1.1M (US$1.5 million) over two years from the UK's Technology Strategy Board under its regenerative medicine program for a project to improve the characterization of human stem cells...Cellzome will use its Episphere technology in collaboration with Neusentis, a Cambridge, UK, subsidiary of New York-based Pfizer Inc., the University of Sheffield and Plasticell Ltd., of London, to identify protein fingerprints that predict potentially

Epithelial stem cell specialist Epistem plc, of Manchester, UK, raised £2.8 million (US$4.4 million) before expenses through a placing of 793,398 shares of 1.5 pence each with existing and new institutional investors...Fetal stem cell specialist ReNeuron Group plc, of Guildford, UK, gave an update on progress with the clinical trial of its ReN001 neural stem cell therapy in the treatment of patients disabled by stroke

The two teamed up in 2007 to combine human pluripotent stem cell biology expertise from Gordon Keller, head of UHN's McEwen Centre for Regenerative Medicine in Toronto, with VistaGen's Human Clinical Trials in a Test Tube stem cell technology platform

Aldagen Inc., of Durham, N.C., published a paper in the Journal of Stem Cell Research & Therapy describing the mechanisms by which its cell therapy products promoted formation of new blood vessels in ischemic tissues

The firms inked the deal in 2006 to work on MultiStem, an adult stem cell-derived product for cardiovascular indications such as acute myocardial infarction

Mesoblast Ltd., of Melbourne, Australia, said preclinical data showed a single intravenous injection of its allogeneic adult stem cell product, Mesenchymal Precursor Cells, lowered blood sugar in animal models of Type II diabetes

Mesoblast Ltd., of Melbourne, Australia, received regulatory clearance from the Singapore Health Sciences Authority to begin the first Phase II trial of its allogeneic adult stem cell therapy for patients with neovascular (wet) age-related macular degeneration (AMD

Geron Corp., of Menlo Park, Calif., reported data on the use of GRNOPC1 , oligodendrocyte progenitors derived from human embryonic stem cells, for myelin repair in a non-human primate model

The company decided to examine the possibility of testing its cardiac stem cell treatment outside of the U.S...in light of the progress toward its trial of UMK-121, its stem cell treatment for patients awaiting liver transplant to overcome end-stage liver disease in the U.S. Conducting the trial offshore will help reduce costs, Proteonomix said